跳至主要内容
临床试验/NCT00865488
NCT00865488暂停3 期

A Prospective, Controlled, Randomized, Multi-Center, Pivotal Study Evaluating the Safety and Efficacy of AdhexilTM in Prevention And/Or Reduction of Adhesions in Gynecology Surgery

OMRIX Biopharmaceuticals5 个研究点 分布在 5 个国家目标入组 80 人开始时间: 2009年5月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
暂停
入组人数
80
试验地点
5
主要终点
Adhesions will be assessed according to incidence, extent and severity.

研究概览

简要总结

The objective of this study is to evaluate the safety and efficacy of ADHEXIL™ in preventing and/or reducing post-operative adhesions in patients undergoing surgery involving the ovaries.

详细描述

Patients will be divided into two arms: 1) patients who will be treated in accordance with standard of care; 2) patients for which ADHEXIL™ will be applied on one ovary and fallopian tube.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Female patients aged 18-45 years at screening.
  • •Patients undergoing elective laparoscopic surgery involving at least one adnexa.

排除标准

  • •Pregnant (including ectopic pregnancy) or breastfeeding patient.
  • •Patients with a documented diagnosis of cancer.
  • •Patients with a lymphatic, hematologic or coagulation disorder.
  • •Patients with a known or suspected hypersensitivity to blood, blood products or any constituent of Adhexil™.
  • •Patients who are immunocompromised, possess autoimmune disorders, or who are routinely taking anticoagulants.
  • •Patients who have participated in another clinical study within 30 days of enrolment.
  • •Investigator's opinion that the patient is medically unfit or would be at major risk if enrolled into the study.

研究组 & 干预措施

1

No Intervention

patients who will be treated in accordance with standard of care

2

Experimental

patients for which Adhexil will be applied to prevent/reduce adhesions

干预措施: ADHEXIL (Biological)

结局指标

主要结局

Adhesions will be assessed according to incidence, extent and severity.

时间窗: 8 weeks post surgery

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (5)

Loading locations...

相似试验